Maintain your employer brand in a pandemic
This article is part of a Technology and Innovation Insights series paid for by Samsung.
As the race to save the world from the COVID-19 pandemic barrels on, and teams around the globe work tirelessly to develop effective therapeutics and vaccines, we have all become acutely aware of the potential for new breakthroughs in the biosciences. What are we learning from this global effort and how can we accelerate the delivery of new drugs and vaccines to fight current and future diseases more effectively? The answer will likely come from advances initiated by biotech startups, aided by new data processing and artificial intelligence.
In this new episode of Samsung’s “The Next Wave” interview series, Young Sohn, Samsung’s President and Chief Strategy Officer, speaks with Rafaèle Tordjman, President and Founder of
This article was originally published on on VentureBeat.
Click here to read the rest of the article.